ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,305Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 384

$295K Total Retail Price of All Prescriptions

Rank: 119 out of 384

279 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 279 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 5,965 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
LEVOTHYROXINE SODIUM 426 373 1 11
RANITIDINE HCL 320 200 2 7
METFORMIN HCL 297 210 3 2
OMEPRAZOLE 272 164 4 8
ENALAPRIL MALEATE 253 186 5 6
ATORVASTATIN CALCIUM 250 192 6 22
SIMVASTATIN 248 184 7 1
NABUMETONE 239 155 8 34
ATENOLOL 216 135 9 12
GABAPENTIN 192 140 10 4
HYDROCHLOROTHIAZIDE 192 149 10 16
RAMIPRIL 144 88 12 51
TRAMADOL HCL-ACETAMINOPHEN 142 78 13 13
DOXAZOSIN MESYLATE 137 137 14 29
TAMSULOSIN HCL 131 113 15 25
SYNTHROID 106 70 16 9
DEXAMETHASONE 105 70 17 117
METHYLPREDNISOLONE 98 49 18 144
SURE COMFORT 98 82 18 96
AMLODIPINE BESYLATE 96 64 20 3
FUROSEMIDE 95 64 21 17
ENALAPRIL-HYDROCHLOROTHIAZIDE 87 56 22 134
DICLOFENAC SODIUM 87 62 22 81
LISINOPRIL 86 81 24 14
NAPROXEN 81 60 25 129
LANSOPRAZOLE 78 59 26 86
METOPROLOL TARTRATE 72 49 27 15
ATENOLOL-CHLORTHALIDONE 72 41 27 173
LANTUS 70 68 29 42
DOXEPIN HCL 70 61 29 89
AMITRIPTYLINE HCL 70 43 R 29 75
BETAMETHASONE DIPROPIONATE 69 45 32 175
LOSARTAN-HYDROCHLOROTHIAZIDE 69 52 32 10
LOVASTATIN 60 39 34 80
GLIMEPIRIDE 57 34 35 18
NAPROXEN SODIUM 56 33 36 164
CARVEDILOL 56 45 36 23
GLYBURIDE 55 33 R 38 82
ISOSORBIDE MONONITRATE ER 55 52 38 28
HUMULIN 70-30 54 46 40 47
PANTOPRAZOLE SODIUM 54 43 40 39
DONEPEZIL HCL 53 53 42 33
METOPROLOL SUCCINATE 53 42 42 21
CEFPROZIL 51 35 44 460
HUMULIN N 51 39 44 57
ZOLPIDEM TARTRATE 50 45 46 19
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.